Greater Cannabis Company (GCAN) Debt to Equity (2016 - 2022)
Greater Cannabis Company has reported Debt to Equity over the past 7 years, most recently at -$0.48 for Q4 2022.
- For Q4 2022, Debt to Equity rose 13.91% year-over-year to -$0.48; the TTM value through Dec 2022 reached -$0.48, up 13.91%, while the annual FY2022 figure was -$0.48, 13.91% up from the prior year.
- Debt to Equity for Q4 2022 was -$0.48 at Greater Cannabis Company, down from -$0.46 in the prior quarter.
- Over five years, Debt to Equity peaked at $3.3 in Q1 2018 and troughed at -$3.01 in Q2 2021.
- A 5-year average of -$0.28 and a median of -$0.46 in 2020 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: plummeted 5564.81% in 2018 and later soared 86.53% in 2022.
- Year by year, Debt to Equity stood at -$0.46 in 2018, then surged by 63.55% to -$0.17 in 2019, then plummeted by 452.79% to -$0.93 in 2020, then soared by 40.35% to -$0.55 in 2021, then increased by 13.91% to -$0.48 in 2022.
- Business Quant data shows Debt to Equity for GCAN at -$0.48 in Q4 2022, -$0.46 in Q3 2022, and -$0.41 in Q2 2022.